Crown and these ASX 200 shares just crashed to multi-year lows

Crown Resorts Ltd (ASX:CWN) and these ASX 200 shares have just crashed to multi-year lows. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With the share market in selloff mode on due to coronavirus concerns, it will come as no surprise to learn that a number of shares sank notably lower.

Three shares that fell so much they hit 52-week lows are listed below. Here's why they are down in the dumps:

a woman

Crown Resorts Ltd (ASX: CWN)

The Crown Resorts share price dropped to a multi-year low of $10.67 this morning. Investors have been selling the casino operator's shares amid concerns over the impact of the coronavirus outbreak on its business. This comes at a time when Crown is already struggling with subdued VIP play. In the first half, the company reported an 11% decline in normalised net profit after tax to $172.7 million. If the coronavirus sticks around for longer than expected, this could weigh heavily on visitor numbers and ultimately its second half profits.

G8 Education Ltd (ASX: GEM)

The G8 Education share price tumbled to a seven-year low of $1.65 today. This follows the release of the childcare centre operator's full year results on Monday. For the 12 months ended December 31, G8 Education reported a 7.2% increase in revenue to $920.1 million but a 3.9% decline in underlying net profit after tax to $76.4 million. The decline in profits was driven by a sharp increase in operating expenses due to its investment in quality, as well as the ramp‐up of its greenfield portfolio. Looking ahead, management warned that trading conditions have deteriorated due to the bushfires and coronavirus outbreak.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price sank to a multi-year low of 32 cents on Tuesday. Investors have been heading to the exits in their droves this month following the release of the pharmaceutical company's disappointing half year result. In the first half of FY 2020, Mayne Pharma posted a 17% decline in revenue to $227.2 million and a 42% decline in underlying EBITDA to $47.4 million. Sustained price deflation in the generic drugs market in the United States has weighed heavily on its performance and shows no signs of easing any time soon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Crown Resorts Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »